Health Care·Biotechnology·$5.5B
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $-1.02 | N/A | -20.43% |
| Revenue | N/A | N/A | N/A |
management commentary, guidance changes, and full analysis available with Pro.
| EPS | $-1.02 | N/A | -20.43% |
| Revenue | N/A | N/A | N/A |
Tone: Defensive
Management acknowledged the difficulties faced this quarter, particularly in terms of EPS. They remain committed to their strategic goals.
Management highlighted ongoing challenges in achieving profitability.
They emphasized a focus on long-term growth despite short-term setbacks.
Scholar Rock's earnings report shows a larger-than-expected loss per share, which may raise concerns among investors about the company's profitability. However, the stock rose by 3.85%, indicating that investors may be optimistic about future growth potential or other factors not reflected in the EPS. The lack of revenue data and guidance leaves some uncertainty about the company's financial trajectory.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
US FOODS HLDG CORP
Nov 8, 2021